Top FDA official Pazdur raises alarm about expediting approvals, Washington Post reports

Top FDA official Pazdur raises alarm about expediting approvals, Washington Post reports

The U.S. Food and Drug Administration's new head of the drug evaluation department, Richard Pazdur, has raised concerns about the legality and pace of new initiatives to expedite decisions, the Washington Post reported on Friday, citing three people familiar with the matter.

Top U.S. FDA drug regulator Richard Pazdur raises alarms about expediting approvals

Nov 21 Top U.S. FDA drug regulator Richard Pazdur raises alarms about expediting approvals - Washington Post ... -November 21, 2025 at 05:25 pm EST MarketScreener

Top FDA drug regulator raises alarms about expediting approvals

Richard Pazdur, who assumed his new role this month, has warned that new Trump administration initiatives could be illegal and pose a risk to public health.